Treatment options are limited for patients with Waldenstrom’s macroglobulinemia (WM), says Morie A. Gertz, MD. Combination therapies offer a potential solution, but the rarity of the disease is an obstacle. The disease occurs in roughly 4 patients per million, per… Continue reading
IMBRUVICA® is an oral, once-daily, single-agent therapy associated with a durable response in patients with this rare B-cell lymphoma
TORONTO, May 12, 2016 /CNW/ – Janssen Inc. announced today that Health Canada has issued… Continue reading
Shelby Bell Knowlton is undertaking a Tough Mudder competition on June 18th in Whistler, BC. She will be donating 100% of donations to the WMFC. We are so very appreciative of this courageous father/daughter team and invite you to support… Continue reading
Waldenstrom’s Macroglobulinemia (Lymphoplasmacytic Lymphoma)
If you have Waldenstrom’s Macroglobulinemia (WM) or you are a caregiver of a patient with WM, you can help by completing the surveys.
Lymphoma Canada, in partnership with the Canadian Organization… Continue reading
April 4, 2016 – We are pleased to announce that Health Canada has approved Ibrutinib for WM patients in Canada. The decision was based on sponsored study data. Information has yet to be released on the funding of the… Continue reading
We are pleased to offer “Anticancer: A New Way of Life” by David Servan-Shreiber to the lending library.
Email to borrow
With more than 1 million copies sold in thirty-five languages in close to fifty countries, Anticancer has been acclaimed… Continue reading
This great guide is helpful in helping make healthy choices for you and your home.
June 10-12, 2016
Omni Providence Hotel
The IWMF Educational Forum has something for everyone. From presentations addressing symptoms and complications, treatments, new therapies in the works and research findings by specialists of Waldenstrom’s Macroglobulinemia… Continue reading
We encourage everyone to participate in the Global Patient Survey conducted by the Lymphoma Coalition. The Lymphoma Coalition is a worldwide network of Hodgkin’s and non-Hodgkin’s lymphoma patient groups. The survey is for lymphoma patients and caregivers with the results… Continue reading